AlzeCure Pharma (Sweden) Buy Hold or Sell Recommendation
| ALZCUR Stock | SEK 2.00 0.08 3.85% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding AlzeCure Pharma is 'Strong Sell'. Macroaxis provides AlzeCure Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ALZCUR positions. The advice algorithm takes into account all of AlzeCure Pharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting AlzeCure Pharma's buy or sell advice are summarized below:
Real Value 1.96 | Hype Value 2.08 | Market Value 2 | Naive Value 2.81 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell AlzeCure Pharma given historical horizon and risk tolerance towards AlzeCure Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for AlzeCure Pharma, the advice is generated through an automated system that utilizes algorithms and statistical models.
AlzeCure |
Execute AlzeCure Pharma Buy or Sell Advice
The AlzeCure recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on AlzeCure Pharma. Macroaxis does not own or have any residual interests in AlzeCure Pharma or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute AlzeCure Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Extremely Dangerous | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
AlzeCure Pharma Trading Alerts and Improvement Suggestions
| AlzeCure Pharma generated a negative expected return over the last 90 days | |
| AlzeCure Pharma has high historical volatility and very poor performance | |
| AlzeCure Pharma has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (77.78 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| AlzeCure Pharma has accumulated about 222.05 M in cash with (70.64 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.88, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 41.0% of the company shares are held by company insiders |
AlzeCure Pharma Returns Distribution Density
The distribution of AlzeCure Pharma's historical returns is an attempt to chart the uncertainty of AlzeCure Pharma's future price movements. The chart of the probability distribution of AlzeCure Pharma daily returns describes the distribution of returns around its average expected value. We use AlzeCure Pharma price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of AlzeCure Pharma returns is essential to provide solid investment advice for AlzeCure Pharma.
| Mean Return | -0.37 | Value At Risk | -10.67 | Potential Upside | 13.77 | Standard Deviation | 8.30 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of AlzeCure Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
AlzeCure Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to AlzeCure Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that AlzeCure Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a AlzeCure stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.27 | |
β | Beta against NYSE Composite | -1.92 | |
σ | Overall volatility | 8.35 | |
Ir | Information ratio | -0.05 |
AlzeCure Pharma Volatility Alert
AlzeCure Pharma is displaying above-average volatility over the selected time horizon. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure AlzeCure Pharma's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact AlzeCure Pharma's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.AlzeCure Pharma Fundamentals Vs Peers
Comparing AlzeCure Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze AlzeCure Pharma's direct or indirect competition across all of the common fundamentals between AlzeCure Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as AlzeCure Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of AlzeCure Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing AlzeCure Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare AlzeCure Pharma to competition |
| Fundamentals | AlzeCure Pharma | Peer Average |
| Return On Equity | -1.55 | -0.31 |
| Return On Asset | -0.78 | -0.14 |
| Current Valuation | 173.51 M | 16.62 B |
| Shares Outstanding | 59.19 M | 571.82 M |
| Shares Owned By Insiders | 41.31 % | 10.09 % |
| Shares Owned By Institutions | 6.48 % | 39.21 % |
| Price To Book | 6.62 X | 9.51 X |
| EBITDA | (77.2 M) | 3.9 B |
| Net Income | (77.78 M) | 570.98 M |
| Cash And Equivalents | 222.05 M | 2.7 B |
| Cash Per Share | 5.88 X | 5.01 X |
| Current Ratio | 48.05 X | 2.16 X |
| Book Value Per Share | 0.63 X | 1.93 K |
| Cash Flow From Operations | (70.64 M) | 971.22 M |
| Earnings Per Share | (1.78) X | 3.12 X |
| Target Price | 11.88 | |
| Number Of Employees | 14 | 18.84 K |
| Beta | 0.76 | -0.15 |
| Market Capitalization | 254.44 M | 19.03 B |
| Total Asset | 45.65 M | 29.47 B |
| Z Score | -3.3 | 8.72 |
| Net Asset | 45.65 M |
AlzeCure Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as AlzeCure . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About AlzeCure Pharma Buy or Sell Advice
When is the right time to buy or sell AlzeCure Pharma? Buying financial instruments such as AlzeCure Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having AlzeCure Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Marketing Thematic Idea Now
Marketing
Companies providing marketing and public relation (PR) services as well as news and media distribution. The Marketing theme has 40 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Marketing Theme or any other thematic opportunities.
| View All Next | Launch |
Check out AlzeCure Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for AlzeCure Stock analysis
When running AlzeCure Pharma's price analysis, check to measure AlzeCure Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AlzeCure Pharma is operating at the current time. Most of AlzeCure Pharma's value examination focuses on studying past and present price action to predict the probability of AlzeCure Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AlzeCure Pharma's price. Additionally, you may evaluate how the addition of AlzeCure Pharma to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |